Registered Kenya · PPB

LOPADINE EYE DROPS

OLOPATADINEHCL 1MG

H2019/4837/1066ER 5.55MG/5ML GENERIC/BIOSIMILARS

What it does

Olopatadine is used to relieve allergy symptoms, such as itchy or watery eyes.

Commonly used for: allergic conjunctivitis, eye allergies

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.

Source this medicine

Registration & product details

Registration no.
H2019/4837/1066ER
Registration date
2019-02-21 00:00:00
Expiry date
-
Status
Registered
Active ingredient
OLOPATADINEHCL 1MG
Dosage form
5.55MG/5ML
Strength
-
Pack size
1'S
Therapeutic class
GENERIC/BIOSIMILARS
Manufacturer / MAH
Radiance Pharmaceuticals
Country of origin
FOREIGN
Manufacturer location
Eastern Bypass, Kenya

Source: Pharmacy and Poisons Board · fetched 2026-01-28 19:45:00 · updated 2026-08-03 02:54:02

Disclaimer: This information is sourced from Pharmacy and Poisons Board (Kenya). Always consult a qualified healthcare professional before using any medication.

About this medicine

Olopatadine is used to relieve allergy symptoms, such as itchy or watery eyes.

What it treats

  • allergic conjunctivitis
  • eye allergies

How it works

Olopatadine works by blocking the action of certain substances in the body that cause allergic symptoms.

Who it's for

It is suitable for adults and children who suffer from allergy-related eye problems.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: olopatadinehcl

Olopatadine hydrochloride is a selective antihistamine used primarily for the treatment of allergic conjunctivitis and allergic rhinitis. It works by blocking the action of histamine, a substance in the body that causes allergic symptoms. Olopatadine is known for its dual action as both an antihistamine and a mast cell stabilizer, providing relief from ocular itching and inflammation associated with allergic reactions.

Indications

  • Allergic conjunctivitis
  • Allergic rhinitis
  • Seasonal allergic rhinitis

Dosage

Children: Refer to the BNF for Children for specific dosing recommendations based on age and indication.

Adults: Refer to the BNF for specific dosing guidelines based on the formulation and indication.

Mechanism of action

Olopatadine acts as a selective antagonist of the H1 histamine receptor. By binding to these receptors, it inhibits the action of histamine, thereby reducing symptoms such as itching and redness in allergic reactions. Additionally, olopatadine stabilizes mast cells and prevents the release of histamine and other inflammatory mediators, contributing to its anti-inflammatory effects.

Pharmacodynamics

Olopatadine demonstrates a high affinity for H1 receptors, which leads to effective symptom relief in allergic conditions. Its mast cell stabilizing properties contribute to a decrease in the release of various inflammatory mediators, resulting in reduced ocular and nasal symptoms. The onset of action is typically rapid, with peak effects observed within hours after administration.

Pharmacokinetics

Olopatadine is well-absorbed after topical administration, with systemic absorption being minimal. It undergoes hepatic metabolism, primarily through glucuronidation, with renal excretion of metabolites. The elimination half-life allows for once or twice daily dosing, depending on the formulation used, either as an eye drop or nasal spray.

Adverse effects

  • Headache
  • Somnolence
  • Dry mouth
  • Nausea
  • Fatigue

Precautions

  • Use with caution in patients with severe renal impairment
  • Not recommended in patients with hypersensitivity to olopatadine or any of the excipients

Pregnancy

Olopatadine should only be used during pregnancy if the potential benefit justifies the potential risk to the fetus. Limited data is available on its safety during pregnancy.

Breast-feeding

Olopatadine is excreted in breast milk. Caution should be exercised when administering to nursing mothers.

Storage

Store at room temperature, away from light and moisture. Keep out of reach of children.

Formulations

  • Ophthalmic solution (0.1% and 0.2%)
  • Oral tablets (antihistamine formulations)

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.